Cargando…
Declining Levels of Neutralizing Antibodies Against SARS-CoV-2 in Convalescent COVID-19 Patients One Year Post Symptom Onset
Major advances have been made in understanding the dynamics of humoral immunity briefly after the acute coronavirus disease 2019 (COVID-19). However, knowledge concerning long-term kinetics of antibody responses in convalescent patients is limited. During a one-year period post symptom onset, we lon...
Autores principales: | Xiang, Tiandan, Liang, Boyun, Fang, Yaohui, Lu, Sihong, Li, Sumeng, Wang, Hua, Li, Huadong, Yang, Xiaoli, Shen, Shu, Zhu, Bin, Wang, Baoju, Wu, Jun, Liu, Jia, Lu, Mengji, Yang, Dongliang, Dittmer, Ulf, Trilling, Mirko, Deng, Fei, Zheng, Xin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242354/ https://www.ncbi.nlm.nih.gov/pubmed/34220870 http://dx.doi.org/10.3389/fimmu.2021.708523 |
Ejemplares similares
-
SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19
por: Wu, Jun, et al.
Publicado: (2021) -
SARS-CoV-2-specific T cell responses wane profoundly in convalescent individuals 10 months after primary infection
por: Li, Ziwei, et al.
Publicado: (2023) -
Characterization of SARS-CoV-2-Specific Humoral and Cellular Immune Responses Induced by Inactivated COVID-19 Vaccines in a Real-World Setting
por: Li, Ziwei, et al.
Publicado: (2021) -
Robust humoral and cellular immune responses in long-term convalescent COVID-19 individuals following one-dose SARS-CoV-2 inactivated vaccination
por: Liang, Boyun, et al.
Publicado: (2022) -
A Crowned Killer’s Résumé: Genome, Structure, Receptors, and Origin of SARS-CoV-2
por: Wang, Shichuan, et al.
Publicado: (2020)